PGT-A testing is a genetic screening method used during IVF to check embryos for certain chromosome abnormalities before an embryo transfer. It can provide additional information about embryo chromosome status and may help doctors decide which embryos are suitable for transfer in selected IVF cases.

However, PGT-A is not necessary for every person undergoing IVF. Its usefulness can depend on factors such as age, previous IVF outcomes, miscarriage history, embryo numbers, and individual fertility circumstances.

If you are considering PGT-A before IVF, understanding how the test works, who may benefit, its limitations, and the potential cost can help you have a more informed discussion with your fertility specialist.

What Is PGT-A Testing?

PGT-A stands for Preimplantation Genetic Testing for Aneuploidy. Aneuploidy refers to an abnormal number of chromosomes in an embryo.

During IVF, embryos are created in the laboratory. Once an embryo reaches the blastocyst stage, a small number of cells can be removed from the outer layer of the embryo. The sample is then analyzed for chromosome abnormalities.

The embryo itself is generally not transferred immediately after the biopsy. Embryos are usually frozen while the genetic testing results are processed. Based on the results and the overall clinical situation, the fertility team may recommend an embryo for transfer.

Importantly, PGT-A is a screening test. It does not test for every possible genetic or medical condition.

How Does PGT-A Before IVF Work?

The PGT-A before IVF process generally follows several stages:

1. Ovarian stimulation: Fertility medications are used to stimulate the ovaries to develop multiple eggs.

2. Egg retrieval: Mature eggs are collected during a medical procedure.

3. Fertilization: Eggs are fertilized with sperm in the laboratory using IVF or, when appropriate, ICSI.

4. Embryo development: The resulting embryos are monitored until they reach the blastocyst stage.

5. Embryo biopsy: A small number of cells are collected from the embryo's outer layer.

6. Genetic testing: The biopsy sample is analyzed for chromosome abnormalities.

7. Embryo freezing: Embryos are generally frozen while the results are being processed.

8. Embryo transfer: Depending on the results and clinical factors, an embryo may later be selected for transfer.

The exact process can vary between fertility clinics and individual treatment plans.

Who May Benefit From PGT-A?

PGT-A may be considered in certain IVF situations, but it is not automatically recommended for everyone.

A fertility specialist may discuss PGT-A with patients who have:

1. Advanced Maternal Age

The likelihood of chromosome abnormalities in embryos tends to increase with maternal age. Therefore, PGT-A may be discussed more often with patients undergoing IVF at an older reproductive age.

Age alone, however, does not determine whether PGT-A will be useful.

2. Recurrent Pregnancy Loss

Some miscarriages are associated with chromosome abnormalities in embryos. For people with recurrent pregnancy loss, a doctor may discuss whether embryo chromosome screening could provide useful information.

However, recurrent miscarriage can have many causes, so PGT-A is not a universal solution.

3. Previous IVF Failure

People who have experienced repeated unsuccessful IVF cycles may ask about genetic testing embryos IVF as part of a broader review of possible factors affecting treatment outcomes.

The potential value of PGT-A depends on the number and quality of embryos available and the individual's reproductive history.

4. A Limited Number of Embryos

This is an important consideration. PGT-A can provide information about embryos, but if very few embryos are available, there may be fewer embryos from which to choose.

In some cases, the testing process may not identify a suitable embryo for transfer.

5. Previous Aneuploid Embryos

If previous IVF testing has identified chromosome abnormalities in embryos, a fertility specialist may discuss PGT-A for a subsequent cycle.

Does PGT-A Improve IVF Success Rate?

The relationship between PGT-A success rate and IVF success is more complicated than simply saying that PGT-A increases the chance of pregnancy.

PGT-A can help identify embryos with chromosome results that are more consistent with euploid embryos, potentially reducing the number of embryos transferred and helping with embryo selection in appropriate cases.

However, PGT-A does not guarantee implantation, pregnancy, or a live birth.

Its potential benefit also depends on factors such as:

• Maternal age

• Number of eggs retrieved

• Embryo development

• Embryo quality

• Sperm factors

• Uterine and endometrial factors

• Number of embryos available for testing

• Laboratory quality

• Individual medical history

A key point is that PGT-A evaluates chromosome status. It does not guarantee that an embryo will implant or result in a healthy baby.

How Much Does PGT-A Cost in India?

The PGT-A cost in India varies considerably between clinics, laboratories, cities, and testing methods.

In many cases, PGT-A is an additional expense on top of the standard IVF treatment cost. The final price can depend on factors such as:

• Number of embryos being tested

• Embryo biopsy charges

• Genetic laboratory fees

• IVF clinic charges

• Embryo freezing and storage

• Consultation and follow-up costs

A rough estimate for PGT-A may range from ₹1 lakh to ₹3 lakh or more, depending on the clinic and number of embryos tested. This is only an indicative range, not a fixed national price.

Before starting treatment, ask the clinic for a written cost breakdown covering IVF, embryo biopsy, genetic testing, freezing, storage, and embryo transfer.

PGT-A vs Regular IVF

PGT-A adds another layer of information to the IVF process, but that does not mean it is automatically the right choice for every patient.

What Are the Limitations of PGT-A?

Before choosing PGT-A, it is important to understand its limitations.

First, not every embryo will necessarily produce a clear or usable test result. Some embryos can also show mosaic results, where different cells contain different chromosome patterns.

Second, PGT-A does not screen for every genetic disease. Other forms of preimplantation genetic testing, such as PGT-M, are used when testing for specific inherited genetic conditions.

Third, PGT-A does not assess every factor that influences pregnancy. Endometrial health, embryo development, sperm factors, maternal age, and other medical factors can still affect IVF outcomes.

Finally, PGT-A adds cost and requires embryo biopsy and freezing procedures.

Questions to Ask Your Fertility Specialist

If you are considering PGT-A testing, ask:

• Why is PGT-A being recommended in my case?

• How many embryos are likely to be available for testing?

• What does the total PGT-A cost include?

• What happens if an embryo receives a mosaic result?

• How long will testing take?

• Will the embryos be frozen while waiting for results?

• How could PGT-A change my embryo-transfer plan?

• What are the alternatives to PGT-A?

These questions can help you understand whether the additional testing fits your individual IVF plan.

Final Takeaway

PGT-A testing can provide valuable information about chromosome abnormalities in embryos created through IVF. It may be considered for some patients based on age, previous IVF outcomes, miscarriage history, or other reproductive factors.

However, PGT-A is a screening tool, not a guarantee of IVF success. The PGT-A cost in India can also add significantly to the overall IVF budget, particularly when several embryos are tested.

If you are considering PGT-A before IVF, discuss your expected number of embryos, medical history, potential benefits, limitations, and complete treatment cost with a qualified fertility specialist before making a decision.

FAQs

Is PGT-A necessary for every IVF patient?

No. PGT-A is not routinely necessary for every IVF patient. Its potential usefulness depends on individual factors such as age, reproductive history, embryo numbers, and previous treatment outcomes.

Does PGT-A guarantee a successful pregnancy?

No. PGT-A can provide information about embryo chromosome status, but it cannot guarantee implantation, pregnancy, or a live birth.

What is the average PGT-A cost in India?

PGT-A pricing varies by clinic, laboratory, city, and number of embryos tested. It may cost around ₹1 lakh to ₹3 lakh or more in some cases, excluding or depending on other IVF-related charges.

Can PGT-A test for all genetic diseases?

No. PGT-A primarily evaluates chromosome number abnormalities. Specific inherited genetic conditions may require other types of preimplantation genetic testing.

Is PGT-A the same as genetic testing for embryos?

PGT-A is one type of genetic testing embryos IVF. It specifically focuses on chromosome number abnormalities, while other PGT methods are designed to detect specific genetic conditions.